Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication January 13, 2009
- Accepted for publication February 25, 2009
- Published online April 29, 2009.
Article Versions
- previous version (April 20, 2009 - 05:42).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009 by Society of Nuclear Medicine
Author Information
- 1Department of Nuclear Medicine, Barts and The London School of Medicine, Queen Mary, University of London, London, United Kingdom; 2Department of Pathology, Technische Universität München, Munich, Germany; and 3Centre for Molecular Oncology and Imaging, Institute of Cancer, Barts and the London School of Medicine and Dentistry, London, United Kingdom
- For correspondence or reprints contact: Norbert Avril, Department of Nuclear Medicine, Barts and The London School of Medicine, Queen Mary, University of London, West Smithfield (QE II), London EC1A 7BE, United Kingdom. E-mail: n.e.avril{at}qmul.ac.uk
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
- Article
- Abstract
- ASSESSMENT OF RESPONSE TO TREATMENT
- MONITORING RESPONSE TO TREATMENT WITH 18F-FDG PET AND PET/CT
- TREATMENT-INDUCED CHANGES IN TUMOR BLOOD FLOW
- MONITORING RESPONSE BY IMAGING CHANGES IN TUMOR CELL PROLIFERATION
- ASSESSMENT OF RESPONSE TO TREATMENT WITH 18F-FDG PET AND PET/CT
- CONCLUSION
- Footnotes
- References
- Figures & Data
- Info & Metrics
Related Articles
Cited By...
- Bevacizumab Induces Acute Hypoxia and Cancer Progression in Patients with Refractory Breast Cancer: Multimodal Functional Imaging and Multiplex Cytokine Analysis
- The Prognostic Impact of Early Change in 18F-FDG PET SUV After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer
- Reporter nanoparticle that monitors its anticancer efficacy in real time
- 18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
- Complexity of Response Evaluation During Primary Systemic Therapy of Breast Cancer: Scoring Systems and Beyond-Preliminary Results
- Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer
- Oncologic PET/MRI, Part 1: Tumors of the Brain, Head and Neck, Chest, Abdomen, and Pelvis
- Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis
- The XbaI G>T Polymorphism of the Glucose Transporter 1 Gene Modulates 18F-FDG Uptake and Tumor Aggressiveness in Breast Cancer
- Assessing Tumor Response to Therapy